~~<i id='1DA1F015F1'><strike id='1DA1F015F1'><tt id='1DA1F015F1'><pre id='1DA1F015F1'></pre></tt></strike></i>~~

Home» knowledge» knowledge

knowledge

author：explore 2025-09-30 14:26:47 Page View：438

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： UCSF medical school apologizes for unethical prisoner experiments
Next article： Virginia high school admissions case could be legal follow

explore

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

1:58AuthoritiesremoveevidenceastheysearchthehomeofsuspectRexHeuermann,Tuesday,July18,2023,inMassapeq

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Study: New antibiotic targets gonorrhea as well as last existing drug

ColorizedscanningelectronmicrographofNeisseriagonorrhoeaebacteria,whichcausesgonorrhea.NIAIDAnimport